Optimal designs for phase II clinical trials with heterogeneous patient populations

Lu LiuDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USAView further author information

Shiwei CaoDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USAView further author information

Sin-Ho JungDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USACorrespondence[email protected]
View further author information

References

Jung, S. H., M. N. Chang, and S. J. Kang. 2012. Phase II cancer clinical trials with heterogeneous patient populations. Journal of Biopharmaceutical Statistics 22 (2):312–328. doi:10.1080/10543406.2010.536873.
PubMed Web of Science ®Google Scholar
London, W. B., and C. M.N. 2005. One- and two-stage designs for stratified phase II clinical trials. Statistics in Medicine 24 (17):2597–2611. doi:10.1002/sim.2139.
PubMed Web of Science ®Google Scholar
Simon, R. 1989. Optimal two-stage designs for phase II clinical trials. Controlled Clinical Trials 10 (1):1–10. doi:10.1016/0197-2456(89)90015-9.
PubMedGoogle Scholar
Sposto, R., and G. P.s. 2009. An adjustment for patient heterogeneity in the design of two-stage phase II trials. Statistics in Medicine 28 (20):2566–2579. doi:10.1002/sim.3624.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Optimal designs for phase II clinical trials with heterogeneous patient populations

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Optimal designs for phase II clinical trials with heterogeneous patient populations

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date